Results 61 to 70 of about 20,949 (222)
Spontaneous Retroperitoneal Hematoma: A Rare Presentation of Polyarteritis Nodosa
Journal of Investigative Medicine High Impact Case Reports, 2019 Spontaneous retroperitoneal hematoma is a rare clinical entity that is most commonly caused by renal tumors and vascular disease. In this article, we present a case of spontaneous retroperitoneal hemorrhage caused by polyarteritis nodosa in a patient who
Asad Ullah MD +4 more
doaj +1 more source
Olaparib‐associated cutaneous vasculitis in a patient with breast cancer
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcial Álvarez‐Salafranca +3 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Direct oral anticoagulants (DOACs), including edoxaban, are widely used for stroke prevention in atrial fibrillation and venous thromboembolism. While gastrointestinal bleeding and diarrhea are recognized adverse effects, DOAC‐induced enterocolitis has not been established as a distinct clinical entity.
Katsuya Endo +8 more
wiley +1 more source
Childhood polyarteritis nodosa: A rare presentation
Asian Journal of Medical Sciences, 2016 Polyarteritis nodosa (PAN) is a rare systemic vasculitis characterized by necrotizing arteritis of small to medium-sized arteries. It manifests as skin ulceration, hypertension, abdominal pain, digital gangrene, subcutaneous nodules etc.
Sandeep Lahiry
doaj +1 more source
Polyarteritis nodosa: decreasing incidence in Poland
Archives of medical science : AMS, 2017 Introduction There are many studies on the epidemiology of the orphan disease polyarteritis nodosa (PAN) in European countries. The use of a hospital morbidity database is an important element of epidemiological analysis.
K. Kanecki +5 more
semanticscholar +1 more source
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 945-954, April 2026.Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak +2 more
wiley +1 more source
Cutaneous polyarteritis nodosa
British Journal of Dermatology, 2002 Classic polyarteritis nodosa (PAN) is a segmentary leucocytoclastic vasculitis that affects small- and medium-sized arteries. In 1931, Lindberg (Acta Med Scand 1931; 76: 183-225) described the existence of a cutaneous variant of PAN, without visceral involvement and with a more favourable prognosis. We present four patients diagnosed with cutaneous PAN
España, A. (Agustín) +2 more
openaire +3 more sources
The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab
Internal medicine, 2017 Polyarteritis nodosa (PAN), characterized by arteritis of medium-sized blood vessels, is usually treated with a combination of glucocorticoids and immunosuppressants; however, some cases are refractory to these treatments.
S. Matsuo +9 more
semanticscholar +1 more source
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis
ACR Open Rheumatology, Volume 8, Issue 3, March 2026.Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano +4 more
wiley +1 more source